1548 Stock Overview
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People’s Republic of China, Japan, the other Asia Pacific regions, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Genscript Biotech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$9.15 |
| 52 Week High | HK$24.95 |
| 52 Week Low | HK$7.43 |
| Beta | 1.07 |
| 1 Month Change | -24.38% |
| 3 Month Change | -36.37% |
| 1 Year Change | -50.81% |
| 3 Year Change | -72.56% |
| 5 Year Change | -50.43% |
| Change since IPO | 593.18% |
Recent News & Updates
Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch
Jun 05
A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)
May 10Recent updates
Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch
Jun 05A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)
May 10Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 13Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%
Mar 13Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 26Is Genscript Biotech (HKG:1548) A Risky Investment?
Nov 21Is Genscript Biotech (HKG:1548) A Risky Investment?
Aug 22Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook
Apr 04Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report
Apr 03Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 02Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate
Feb 07What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?
Dec 14Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate
Nov 09Is Genscript Biotech (HKG:1548) Using Debt Sensibly?
Oct 22Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?
Apr 03Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?
Oct 03Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Sep 07Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)
Aug 16Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Jun 03Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?
May 13Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
Apr 16Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?
Mar 20Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?
Feb 13
Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?
Jan 09Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?
Dec 05Shareholder Returns
| 1548 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | -9.2% | -0.4% | -1.6% |
| 1Y | -50.8% | -68.7% | 0.2% |
Return vs Industry: 1548 exceeded the Hong Kong Life Sciences industry which returned -68.7% over the past year.
Return vs Market: 1548 underperformed the Hong Kong Market which returned 0.2% over the past year.
Price Volatility
| 1548 volatility | |
|---|---|
| 1548 Average Weekly Movement | 10.2% |
| Life Sciences Industry Average Movement | 10.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 1548's share price has been volatile over the past 3 months.
Volatility Over Time: 1548's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 6,937 | Weihui Shao | www.genscript.com |
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People’s Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy. The Life Science Services and Products segment provides products and services in various categories, including DNA synthesis, plasmid DNA preparation, molecular cloning, oligonucleotide synthesis, protein and antibody expression and purification, peptide synthesis, antibody development, IVT RNA production, assay cell line development and vector packing, molecular diagnostics tools, and genome editing tools and reagents, as well as instrument for protein analysis and purification, cell isolation and activation.
Genscript Biotech Corporation Fundamentals Summary
| 1548 fundamental statistics | |
|---|---|
| Market cap | HK$19.45b |
| Earnings (TTM) | -HK$745.66m |
| Revenue (TTM) | HK$6.56b |
3.0x
P/S Ratio-26.1x
P/E RatioIs 1548 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1548 income statement (TTM) | |
|---|---|
| Revenue | US$839.53m |
| Cost of Revenue | US$429.98m |
| Gross Profit | US$409.55m |
| Other Expenses | US$505.03m |
| Earnings | -US$95.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.045 |
| Gross Margin | 48.78% |
| Net Profit Margin | -11.37% |
| Debt/Equity Ratio | 37.7% |
How did 1548 perform over the long term?
See historical performance and comparison